GPT-Rosalind Surfaces Drug Discovery Lead on Cholesterol Transport and Neurons
OpenAI says GPT-Rosalind identified a new drug discovery lead: whether restoring cholesterol transport could protect neurons from degeneration. The lead involves DCTN1, a gene linked to Perry syndrome, a rare neurodegenerative disorder.


